Which symptom at end of life typically requires anticholinergic therapy to manage secretions?

Study for ELNEC 4: Symptom Management in Palliative Care Test with flashcards and multiple choice questions. Hints and explanations included! Get ready for your exam!

Anticholinergic therapy is used to reduce the secretions that accumulate in the airways and mouth at the end of life, often producing the death rattle. By blocking muscarinic receptors, these drugs decrease saliva and bronchial secretions, which helps ease breathing and reduces the audible rattling. In practice, medications like glycopyrrolate or scopolamine are used, often on a regular schedule to keep secretions dampened; glycopyrrolate is commonly favored because it has less penetration into the CNS, which can help minimize confusion in some patients. Side effects can include dry mouth, constipation, urinary retention, or, less commonly, delirium, so dosing is individualized to maximize comfort. Other symptoms—pain, nausea, and anxiety—are managed with opioids, antiemetics, and anxiolytics, not primarily with anticholinergics. So secretions are the symptom that typically benefits from anticholinergic therapy.